Working… Menu

Efavirenz for Patients With Alzheimer's Disease (EPAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03706885
Recruitment Status : Recruiting
First Posted : October 16, 2018
Last Update Posted : December 22, 2020
University Hospitals Cleveland Medical Center
Massachusetts General Hospital
Information provided by (Responsible Party):
Irina Pikuleva, PhD, Case Western Reserve University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 31, 2021
Estimated Study Completion Date : December 31, 2021